Bradley Foster & Sargent Inc Regenxbio Inc. Transaction History
Bradley Foster & Sargent Inc
- $6.18 Billion
- Q2 2025
A detailed history of Bradley Foster & Sargent Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 54,887 shares of RGNX stock, worth $572,471. This represents 0.01% of its overall portfolio holdings.
Number of Shares
54,887Holding current value
$572,471% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RGNX
# of Institutions
181Shares Held
45.1MCall Options Held
103KPut Options Held
100K-
Black Rock Inc. New York, NY8.61MShares$89.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$49.8 Million4.77% of portfolio
-
Jpmorgan Chase & CO New York, NY4.36MShares$45.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.42MShares$35.7 Million0.0% of portfolio
-
State Street Corp Boston, MA1.84MShares$19.2 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $451M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...